Genovate Biotechnology (4130.TWO) Earnings Analysis
Genovate Biotechnology (4130.TWO) has no confirmed upcoming earnings date. Last quarter (2026-05-18) it missed with EPS -0.09 TWD vs 0.09747 TWD est (-192.3%). It has beaten estimates in 0/2 recent quarters (0%). Trailing P/E -422.47.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4130.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4130.TWO. This page updates as the calendar is published.
4130.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-18 | -0.09 TWD | 0.09747 TWD | -192.3% | Miss |
| 2026-01-27 | -0.0318 TWD | 0.2392 TWD | -113.3% | Miss |
| 2025-09-30 | -0.01 TWD | n/a | n/a | n/a |
| 2025-06-30 | 0.06863 TWD | n/a | n/a | n/a |
| 2025-03-20 | -0.04024 TWD | n/a | n/a | n/a |
Beat rate: 0/2 (0%) over reported quarters with consensus data.
4130.TWO valuation and analyst view
| Trailing P/E | -422.47 |
|---|---|
| Trailing EPS | -0.07298 TWD |
| Price / book | 1.68 |
| Dividend yield | 0.36% |
| Market cap | 3.14B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Genovate Biotechnology (4130.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4130.TWO. This page updates as the calendar is published.
Did 4130.TWO beat earnings last quarter?
In its 2026-05-18 report, 4130.TWO posted EPS of -0.09 TWD versus a 0.09747 TWD estimate — a miss of 192.3%.
What is 4130.TWO's earnings track record?
Over the last 2 reported quarters with consensus data, 4130.TWO beat estimates 0 times (0%).
What is 4130.TWO's current P/E ratio and EPS?
4130.TWO trades at a trailing P/E of -422.47 on trailing EPS of -0.07298409892586134 TWD.
What do analysts rate 4130.TWO?
4130.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.